You have 9 free searches left this month | for more free features.

Ocular surface inflammation

Showing 1 - 25 of >10,000

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Dry Eye Disease Trial in Lucca (Artificial tear MDI - 101)

Completed
  • Dry Eye Disease
  • Artificial tear MDI - 101
  • Lucca, Italy
    Ophthalmology unit
Dec 1, 2021

Immune Cell Signatures in Autoimmunity and Dry Eye Syndrome

Recruiting
  • Autoimmunity
  • Dry Eye Syndrome
  • Cross-sectional study
  • Singapore, Singapore
    Cynthia Boo
Mar 22, 2022

Ocular Surface Disease, Ocular Inflammation Trial in Rome (CycloSPORINE Ophthalmic 0.1% Ophthalmic Emulsion, cationorm eye

Active, not recruiting
  • Ocular Surface Disease
  • Ocular Inflammation
  • CycloSPORINE Ophthalmic 0.1% Ophthalmic Emulsion
  • cationorm eye drops
  • Rome, Italy
    University Campus Bio Medico
Jan 5, 2022

Croatian Version of Ocular Surface Disease Index Questionnaire

Active, not recruiting
  • Dry Eye
  • Ocular Surface Disease
  • Questionnaires and dry eye tests
  • Zagreb, Croatia
    University Hospital Sestre milosrdnice
Jul 9, 2023

Age-related Cataract Trial in Tours (Ocular Surface Disease Index, Interferometry, Oxford score)

Not yet recruiting
  • Age-related Cataract
  • Ocular Surface Disease Index
  • +5 more
  • Tours, France
    KHANNA
Apr 6, 2023

Ocular Surface Disease Trial in East Kilbride (Autologous blood applied to dry eye)

Completed
  • Ocular Surface Disease
  • Autologous blood applied to dry eye
  • East Kilbride, Lanarkshire, United Kingdom
    Hairmyres Hospital
Apr 14, 2022

Glaucoma, Ocular Hypertensive Trial in Seoul (BRIDIN-plus Eye drops, Combigan Eye drops)

Completed
  • Glaucoma
  • Ocular Hypertensive
  • BRIDIN-plus Eye drops
  • Combigan Eye drops
  • Seoul, Seongnam, Bundang-gu, Korea, Republic of
    Seungsoo Rho
Oct 9, 2023

Ocular Surface Microbiome Trial in Leuven (Conjunctival swab)

Active, not recruiting
  • Ocular Surface Microbiome
  • Conjunctival swab
  • Leuven, Belgium
    University Hospitals Leuven, Department of Ophthalmology
Aug 31, 2022

Ocular Surface Disease in Chronic Graft-Versus-Host Disease

Recruiting
  • Dry Eye
  • GVHD
  • Cross-sectional study
  • Singapore, Singapore
    Cynthia Boo
Mar 22, 2022

Allergic Conjunctivitis Trial in Taichung (Vitamin D, Placebo)

Recruiting
  • Allergic Conjunctivitis
  • Vitamin D
  • Placebo
  • Taichung, Taiwan
    China Medical University Hospital
May 1, 2023

Sentinel Lymph Node Biopsy in Ocular Surface and Adnexal Cancers

Recruiting
  • Ocular Sebaceous Carcinoma
  • +5 more
  • Sentinel Lymph Node Biopsy
  • Roma, Rome, Italy
    Gustavo Savino
Apr 3, 2023

Malignant Pigmented Tumors on Ocular Surface

Recruiting
  • Orbital Neoplasms
  • +2 more
  • screening system for ocular surface malignant tumors
  • Guangzhou, Guangdong, China
    Zhognshan Ophthalmic Center, Sun Yat-sen University
Dec 2, 2022

Dermatochalasis of Eyelid Trial in München (Compression dressing)

Completed
  • Dermatochalasis of Eyelid
  • Compression dressing
  • München, Germany
    Augenklink LMU
Oct 30, 2023

Strip Meniscometry in Dry Eye Evaluation

Completed
  • Dry Eye
  • Dry Eye Disease
  • Central visual acuity
  • +9 more
  • Olomouc, Czechia
    Department of Ophthalmology, University Hospital Olomouc
Nov 1, 2023

2177GCCC:ID'Ing tx Targets and Biomarkers for Ocular Surface

Recruiting
  • Dry Eye Disease
  • oGVHD
  • The standard care exam and biological specimens' collection
  • Baltimore, Maryland
    Geenebaum Cancer Center, University of Maryland Medical Center
Jun 2, 2022

Ocular Surface in Primary Open Angle Glaucoma or Ocular

Recruiting
  • Glaucoma, Open-Angle
  • Ocular Hypertension
    • Valladolid, Spain
      IOBA
    Jan 28, 2022

    Graft Vs Host Disease Trial in Boston (DEXTENZA (dexamethasone ophthalmic insert) 0.4 mg, for intracanalicular use, Regular

    Withdrawn
    • Graft Vs Host Disease
    • DEXTENZA (dexamethasone ophthalmic insert) 0.4 mg, for intracanalicular use
    • Regular dissolvable intracanalicular plug
    • Boston, Massachusetts
      Mass Eye and Ear
    Dec 14, 2021

    Dry Eye Trial in Wilkes-Barre (Lifitegrast 5% Ophthalmic Solution)

    Enrolling by invitation
    • Dry Eye
    • Lifitegrast 5% Ophthalmic Solution
    • Wilkes-Barre, Pennsylvania
      Bucci Laser Vision
    Sep 28, 2021

    Ocular Discomfort in Glaucoma Patients Using Multiple Topical

    Recruiting
    • Glaucoma
    • Ocular Surface Disease
    • Xiidra (Lifitegrast ophthalmic solution) 5%
    • Fountain Valley, California
      Doheny Eye Center UCLA
    Oct 31, 2022

    Biomarkers in Ocular Inflammation and Uveitis

    Enrolling by invitation
    • Uveitis
    • Ocular Inflammation
      • Bethesda, Maryland
        National Eye Institute (NEI)
      Aug 24, 2022

      Intravitreal Injection, Ocular Rinse, Age-Related Macular Degeneration Trial in Oklahoma City (OSDI questionnaire, SPEEDII

      Completed
      • Intravitreal Injection
      • +4 more
      • OSDI questionnaire
      • SPEEDII questionnaire
      • Oklahoma City, Oklahoma
        Dean McGee Eye Institute
      Nov 7, 2022

      Diacerein on Ocular Surface Disease in Degenerative Arthritis

      Completed
      • Ocular Surface Disease
      • +2 more
      • Bangkok, Thailand
        Faculty of medicine, Chulalongkorn university
      Aug 9, 2021

      Meibomian Gland Dysfunction of Unspecified Eye, Unspecified Eyelid Trial in Tianjin (Routine preoperative and postoperative

      Completed
      • Meibomian Gland Dysfunction of Unspecified Eye, Unspecified Eyelid
      • Routine preoperative and postoperative anti-infection therapy
      • +2 more
      • Tianjin, Tianjin, China
        Tianjin medical university eye hosipital
      Mar 4, 2023

      Glaucoma, Glaucoma; Drugs, Ocular Surface Disease Trial in Alexandroupolis (Intraocular pressure (IOP), Tear Break-up Time

      Recruiting
      • Glaucoma
      • +2 more
      • Intraocular pressure (IOP)
      • +4 more
      • Alexandroupolis, Evros, Greece
        Department of Ophthalmology, University Hospital of Alexandroupo
      Apr 1, 2022

      Ocular Surface Disease Trial in Needham (Restasis)

      Recruiting
      • Ocular Surface Disease
      • Needham, Massachusetts
        BostonSight
      Mar 6, 2022